|
ALXO ALX Oncology Holdings Inc 1810182 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-17,927,000.00 |
| Balance Sheet |
|
Current Assets
|
$145,564,000.00 |
|
Assets
|
$178,328,000.00 |
|
Current Liabilities
|
$20,178,000.00 |
|
Liabilities
|
$26,981,000.00 |
|
Equity
|
$151,347,000.00 |
|
Shares Out
|
134540741.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,648,000.00 |
|
Investing Cash Flow
|
$-105,036,000.00 |
| Market Analysis |
Market Cap
|
$262,354,444.95 |
|
Price
|
$2.00 |
|
BVPS
|
1.12 |
|
PB
|
1.74 |
|
EPS
|
-0.17 |
|
FCF
|
$-18,698,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-27 |
-0.42 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-08 |
-0.17 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.49 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
-0.41 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALXO documents filed with the SEC.
ALXO Filings
Clear
